HSE approval of cystic fibrosis drug hailed as 'wonderful Christmas present' for patients

The first drug to treat the underlying cause of cystic fibrosis (CF) for around 80% of patients in Ireland has been approved by the HSE and is being considered for approval by the European Medicines Agency (EMA).

Trikafta is the first approved treatment that is effective for CF patients aged 12 years and over.